Literature DB >> 1487241

Molecular analysis of type I-A (tyrosinase negative) oculocutaneous albinism.

W S Oetting1, R A King.   

Abstract

Type I oculocutaneous albinism (OCA) is caused by the reduction in or absence of activity of tyrosinase in melanocytes in skin, hair, and the eyes, the result of mutations of the tyrosinase gene. To date, a total of 22 unique mutations in the coding region of tyrosinase have been described in the literature. In this report we present 5 additional mutations of the tyrosinase gene associated with type I-A OCA in four individuals, including 2 missense, 1 frameshift and 2 nonsense mutations, and review the relevant literature on all published mutations. Analysis of the distribution of all identified missense mutations (n = 17) shows that most cluster in three areas of the gene and involve amino acids conserved between humans and the mouse. Two clusters involve the copper A and copper B binding sites and may disrupt the metal ion-protein interaction necessary for enzyme function. The third cluster in exon I could represent a functional domain important in enzyme function such as the tyrosine or the dihydroxyphenylalanine (DOPA) binding site of the enzyme. Small deletions or insertions resulting in frameshift mutations and nonsense mutations are distributed throughout the coding region and do not appear to cluster.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1487241     DOI: 10.1007/bf00220074

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  29 in total

1.  Detection of point mutation in the tyrosinase gene of a Japanese albino patient by a direct sequencing of amplified DNA.

Authors:  H Kikuchi; S Hara; S Ishiguro; M Tamai; M Watanabe
Journal:  Hum Genet       Date:  1990-06       Impact factor: 4.132

2.  Three different frameshift mutations of the tyrosinase gene in type IA oculocutaneous albinism.

Authors:  W S Oetting; M M Mentink; C G Summers; R A Lewis; J G White; R A King
Journal:  Am J Hum Genet       Date:  1991-07       Impact factor: 11.025

3.  Temperature-sensitive tyrosinase associated with peripheral pigmentation in oculocutaneous albinism.

Authors:  R A King; D Townsend; W Oetting; C G Summers; D P Olds; J G White; R A Spritz
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

4.  Biochemistry of melanin formation.

Authors:  A B LERNER; T B FITZPATRICK
Journal:  Physiol Rev       Date:  1950-01       Impact factor: 37.312

5.  Detection of mutations in the tyrosinase gene in a patient with type IA oculocutaneous albinism.

Authors:  R A Spritz; K M Strunk; L B Giebel; R A King
Journal:  N Engl J Med       Date:  1990-06-14       Impact factor: 91.245

6.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia.

Authors:  R K Saiki; S Scharf; F Faloona; K B Mullis; G T Horn; H A Erlich; N Arnheim
Journal:  Science       Date:  1985-12-20       Impact factor: 47.728

7.  Amish albinism: a distinctive autosomal recessive phenotype.

Authors:  W E Nance; C E Jackson; C J Witkop
Journal:  Am J Hum Genet       Date:  1970-09       Impact factor: 11.025

8.  Human oculocutaneous albinism caused by single base insertion in the tyrosinase gene.

Authors:  Y Tomita; A Takeda; S Okinaga; H Tagami; S Shibahara
Journal:  Biochem Biophys Res Commun       Date:  1989-11-15       Impact factor: 3.575

9.  Tyrosinase gene mutations associated with type IB ("yellow") oculocutaneous albinism.

Authors:  L B Giebel; R K Tripathi; K M Strunk; J M Hanifin; C E Jackson; R A King; R A Spritz
Journal:  Am J Hum Genet       Date:  1991-06       Impact factor: 11.025

10.  Non-random distribution of missense mutations within the human tyrosinase gene in type I (tyrosinase-related) oculocutaneous albinism.

Authors:  R A King; M M Mentink; W S Oetting
Journal:  Mol Biol Med       Date:  1991-02
View more
  5 in total

1.  Temperature sensitive oculocutaneous albinism associated with missense changes in the tyrosinase gene.

Authors:  T Wang; C T Waters; T Jakins; J R W Yates; D Trump; K Bradshaw; A T Moore
Journal:  Br J Ophthalmol       Date:  2005-10       Impact factor: 4.638

2.  Molecular and clinical characterization of albinism in a large cohort of Italian patients.

Authors:  Annagiusi Gargiulo; Francesco Testa; Settimio Rossi; Valentina Di Iorio; Simona Fecarotta; Teresa de Berardinis; Antonello Iovine; Adriano Magli; Sabrina Signorini; Elisa Fazzi; Maria Silvana Galantuomo; Maurizio Fossarello; Sandro Montefusco; Alfredo Ciccodicola; Alberto Neri; Claudio Macaluso; Francesca Simonelli; Enrico Maria Surace
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-14       Impact factor: 4.799

3.  Vision in albinism.

Authors:  C G Summers
Journal:  Trans Am Ophthalmol Soc       Date:  1996

4.  Molecular genetic studies and delineation of the oculocutaneous albinism phenotype in the Pakistani population.

Authors:  Thomas J Jaworek; Tasleem Kausar; Shannon M Bell; Nabeela Tariq; Muhammad Imran Maqsood; Asma Sohail; Muhmmmad Ali; Furhan Iqbal; Shafqat Rasool; Saima Riazuddin; Rehan S Shaikh; Zubair M Ahmed
Journal:  Orphanet J Rare Dis       Date:  2012-06-26       Impact factor: 4.123

5.  Genetic Analysis of Oculocutaneous Albinism Type1A (OCA1A) in an Iranian Family.

Authors:  H Pour-Jafari; A Zamanian; B Pour-Jafari
Journal:  Iran J Public Health       Date:  2010-03-31       Impact factor: 1.429

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.